GSPR 1: A New Era of Performance with Safety at the Core

Kamiya Crabtree
A team of profesional-looking people sit around a table, congratulating themselves.

In order to be effective and successful in patient care, the safety and performance of medical devices is paramount. The General Safety and Performance Requirements (GSPRs) are a key aspect of the Medical Device Regulation (MDR) and In Vitro Diagnostic Medical Device Regulation (IVDR), ensuring that medical devices in the European Union (EU) meet high standards of safety and performance. In our new GSPR series, we will take an in-depth look at each of the GSPRs, outlining the key requirements to ensure compliance.

The GSPRs specify the essential requirements that medical devices must meet to be placed on the market, and they cover a wide range of topics including design and manufacturing, risk management, labelling, and instructions for use. Compliance with the GSPRs is mandatory, and failure to meet these requirements can result in serious consequences, such as product recalls, fines, or legal action.

In the first article of the GSPR series, we will be taking a look at GSPR 1:

Devices shall achieve the performance intended by their manufacturer and shall be designed and manufactured in such a way that, during normal conditions of use, they are suitable for their intended purpose. They shall be safe and effective and shall not compromise the clinical condition or the safety of patients, or the safety and health of users or, where applicable, other persons, provided that any risks which may be associated with their use constitute acceptable risks when weighed against the benefits to the patient and are compatible with a high level of protection of health and safety, taking into account the generally acknowledged state of the art.

Understanding GSPR1: The Basics

GSPR 1 is one of the foundational requirements under the IVDR/MDR, to regulate the safety and efficacy of medical devices in the EU. It outlines a comprehensive approach to ensuring that medical devices are safe, effective, and of high quality. This specific requirement focuses on ensuring that the design and manufacturing of these devices must prioritise safety in a way that minimises risk to both patients and users.

The regulation mandates that manufacturers must design their devices with a comprehensive risk management process in place. This includes identifying potential risks and mitigating them through:

  • Design: The design phase involves developing the device in such a way that risks to patient safety and device performance are minimised. This could mean ensuring the device operates effectively under all intended conditions, incorporating fail-safes, or using ergonomic designs that reduce the likelihood of user error.
  • Material selection: Choosing the right materials is crucial to ensure that the device is safe for its intended use. This includes considering factors such as biocompatibility, durability, and potential for allergic reactions or other adverse events.
  • Testing before the device can be marketed or used on patients: Extensive testing is required before the device can be marketed. This involves testing to confirm that the device meets the required safety and performance standards. Testing helps to identify any potential issues that may not have been apparent during the design or material selection phases.

These safeguards are proposed to prevent harm in the short and long term.

GSPR1: Core Principles You Need to Know

  • Risk Management – A robust risk management system lies at the heart of GSPR 1. All possible hazards associated with the device, including any foreseeable misuse, need to be assessed by the manufacturer. These risk assessments must be done throughout the product’s lifetime, from design and development to production and use. One of the key aims is to ensure there is a minimal likelihood of harm, and if risks are identified, they are appropriately mitigated.
  • Quality – GSPR 1 stresses that the design and manufacturing process should ensure that the device maintains its performance for the duration of its use. The conditions that it is subjected to during its intended use should be withstood by the device, and manufacturers are to ensure its durability.
  • Biocompatibility – GSPR 1 mandates that the materials used in medical devices must be compatible with the human body, not causing any adverse reactions. Manufacturers must ensure that the material does not provoke harmful immune responses, toxicity, or irritation, regardless of whether the device will have direct or indirect contact with the patient. Biocompatibility testing is essential to verify that the materials used will not negatively affect patients. This is especially important for implantable devices or those that are used over extended periods.
  • Design Considerations – The design of the device plays a pivotal role in preventing user error. GSPR 1 requires that devices are designed in a way that reduces the risk of incorrect use – whether that be considerations like intuitive user interfaces, clear instructions, or an ergonomic design.

Why GSPR1 Matters: Key Reasons for Compliance

GSPR 1 serves as a cornerstone of patient and user safety. By ensuring that safety and performance are prioritised from the earliest stages of design and manufacturing, this regulation aims to prevent potential harm before it happens.

The requirement also fosters innovation in device design by encouraging manufacturers to continuously evaluate and enhance safety features. With an emphasis on risk management and continual improvement, GSPR 1 not only meets current needs but anticipates future challenges, allowing the medical device industry to respond effectively to evolving healthcare environments and patient needs.

The Bottom Line: GSPR 1’s Impact on the Future

GSPR 1 is fundamental within the MDR and IVDR and underscores the importance of designing and manufacturing devices that prioritise the safety and performance of both patients and users of the medical device. Through rigorous risk management, thought-out material selection, and user-centred design, GSPR 1 seeks to ensure that medical devices do not pose harm to those relying on them for care.

Ultimately, GSPR 1 represents a commitment by the medical device industry to uphold the highest standards of safety and quality, fostering trust in devices that are critical to patient health and wellbeing.

If you’re unsure whether you have the necessary evidence to demonstrate conformity with GSPR requirements, don’t worry – we’re here to help! Contact us today, and our team will provide expert guidance to ensure you’re fully compliant with all relevant GSPRs.

Get in touch now for personalised support and peace of mind!

Related articles

  1. A team of profesional-looking people sit around a table, congratulating themselves.

    Extending the Validity of your IVDD Certificates – Key Dates

    The EU and the MHRA have extended the validity of IVDD certificates, allowing you more time to transition to the IVDR. We explain what this means for manufacturers.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  2. Cybersecurity Vulnerabilities in Medical Devices: FDA Alerts on Contec and Epsimed Monitors

    Patients can be exposed to risks when devices are online. We explore implications for EU MDR/IVDR cybersecurity requirements, including MDCG guidance

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  3. A futuristic-looking factory full of labelled cardboard boxes.

    Decoding UDI: Your Ultimate Guide to Smarter Medical Device Labelling

    The Unique Device Identifier (UDI) ensures medical device traceability and compliance. We break down its structure, Device Identifier (UDI-DI), Production Identifier (UDI-PI) and its role in EUDAMED.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  4. A scientist uses a pipette to prepare lab samples.

    Understanding Risk-Based Classification of In Vitro Medical Devices Under EU IVDR

    The transition from IVDD replaces list-based classification with a risk-based approach. Manufacturers must thoroughly understand the rules outlined in Annex VIII of the IVDR.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  5. A medical team discuss performance data at their desktop computer.

    Key Updates for Navigating EMDN: MDCG 2024-2 Rev.1 & 2021-12 Rev.1

    Release of the updated guidance helps manufacturers navigate the EMDN system for accurate device classification, ensuring market access.

    Ron Sangal Ron Sangal Lead Medical Writer
  6. A lab technician enters samples into a machine.

    From IVDD to IVDR: Ensuring Compliance During the Transitional Period

    Legacy device manufacturers need to manage challenging timelines as well as address transitional provisions and update QMS.

    Shona Richardson Shona Richardson Regulatory Medical Writer
  7. A dated monitor for medical equipment.

    Understanding Clinical Evidence Requirements with MDCG 2020-6

    How can manufacturers ensure legacy devices meet MDR's stringent requirements? Discover how MDCG 2020-6 guidance simplifies the path to compliance.

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  8. A stethoscope laid on a desk of regulatory documentation.

    Clinical benefits of an in vitro diagnostic medical device

    How to determine the clinical benefit of an IVD and successfully incorporate it into regulatory documentation.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  9. EU flags

    Regulation (EU) 2024/1860 - Its impact on EU MDR and IVDR

    How does the recent Regulation (EU) 2024/1860 amendment affect the EU MDR & IVDR?

    Shona Richardson Shona Richardson Regulatory Medical Writer
  10. EU flag

    MDCG 2024-10 - Orphan medical devices

    How to apply MDR pre-market clinical evidence requirements to medical devices intended for limited usage.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  11. Considering a medical device's intended purpose

    A medical device's intended purpose - what is the point?

    How do you define intended purpose, indication for use, intended clinical benefits, and claims?

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  12. Mantra Systems presents EnableChat, your AI-powered MDR & MDCG chatbot

    EnableChat - Your AI-powered MDR and MDCG chatbot

    Search the MDR and MDCG documents in seconds by asking EnableChat your questions.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  13. Searching adverse event databases for vigilance data

    Staying vigilant - A guide to searching for adverse events data

    We discuss the pros and cons of existing adverse event databases for vigilance data searching.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  14. A doctor reading an SSCP document with a patient

    What is Summary of Safety and Clinical Performance (SSCP)?

    We explain what the SSCP is, when you'll need it and what its objectives are.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  15. A woman in a laboratory looking down a microscope

    Scientific Validity Reports – Foundation of the IVDR Performance Evaluation

    Justifying scientific validity is the first step in proving compliance with the IVDR.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  16. A pile of question marks

    Medical Device 'Significant Changes' – Navigating EU MDR Article 120(3) using MDCG 2020-3 rev. 1

    Understand what changes to your medical device are considered 'significant' under EU MDR (2017/745).

    Shen May Khoo Shen May Khoo Junior Regulatory Specialist
  17. A signpost giving unsure directions

    MDR or IVDR - A sibling rivalry?

    A guide to easily understanding whether your device is a medical device or an in vitro diagnostic medical device (IVD).

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  18. An EU and UK flag

    What the latest Brexit U-turn means for CE Marking of medical devices in Great Britain

    Will Great Britain continue to allow the use of the CE mark for medical devices beyond the 2024 deadline?

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  19. A woman writing her own medical device regulation documentation

    Gain confidence, reassurance and control over your EU MDR strategy

    Find out how to build your own technical files within a guided framework while minimising financial outlays.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  20. Racing to achieve MDR compliance

    Still racing to achieve MDR compliance? A transition period update

    On January 6th 2023, the EU commission has adopted the proposal to extend the transition rules of the EU MDR.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  21. A 7-step guide to navigating regulatory requirements for medical device start-ups

    A medical device regulations guide for start-up companies

    We present a 7-step guide to navigating regulatory requirements on a budget.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  22. An update on UKCA Marking of Medical Devices

    UKCA Marking of Medical Devices – An update on the status quo

    We review recently updated requirements for UKCA marking and what it means for your regulatory strategy.

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  23. How to choose a CER writer for your MDR Clinical Evaluation

    Choosing a CER writer for your MDR Clinical Evaluations

    We've compiled a list of considerations that will help you make the right choice when choosing a CER writer.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  24. Achieving MDR Compliance for Class I medical devices

    How to achieve MDR Compliance for Class I medical devices

    We outline a strategy for the regulatory compliance of Class I medical devices.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  25. Literature Search, SOTA Review and Clinical Evaluation

    Literature Search, SOTA Review process and Clinical Evaluation

    We help to demystify the process of systematic search & review of literature for Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  26. Literature Search Protocols & SOTA Reviews for medical devices and what to know before you start

    Literature searches and reviews for medical devices - what to know before you start

    We explain what you should know before beginning a literature search & review for your medical device.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  27. Five useful resources when writing a medical device CER

    Five useful resources when writing a medical device CER

    We outline five of the most useful and trustworthy Clinical Evaluation Report writing resources.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  28. Avoid pitfalls when writing a Clinical Evaluation Report

    Five common pitfalls when writing a Clinical Evaluation Report

    We illustrate five pitfalls when writing CERs and give you some tips to overcome them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  29. How to make a medical device equivalence claim under the MDR

    Five tips for making a medical device equivalence claim under the MDR

    We'll show you what to keep in mind with regards to equivalance and Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  30. Keeping medical devices in market and maintaining CE-marks - a guide to effective data collection

    Keeping medical devices in market and maintaining CE-marks

    The 4 golden rules to drive regulatory compliance with PMCF and vigilance data collection.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  31. How PMCF goes beyond simple compliance - improving products and engaging customers

    How PMCF goes beyond simple compliance

    The wider benefits of a well-designed PMCF system include improving your products and your relationship with your clients.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  32. PMCF systems for medical devices

    Why you'll almost certainly need a PMCF system for your medical devices

    We tell you what to be aware of under the EU MDR regarding PMCF and your medical devices.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  33. Ensure medical device regulatory compliance of your devices through Brexit

    The impact of Brexit on medical device regulatory compliance

    How to ensure regulatory alignment of your devices in the territories affected by Brexit.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  34. Use medical device regulatory consulting services to supercharge your MDR transition

    Is outside consulting support the answer to your MDR transition?

    Getting ready for the MDR is a demanding process. Outsourcing might be your solution.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  35. Increasing data entry compliance in PMCF studies

    Increasing data entry compliance in PMCF studies

    5 methods every medical device manufacturer should know to improve their Post-Market Clinical Follow-up studies.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  36. Why medical doctors can drive MDR compliance

    Why medical doctors can drive MDR compliance

    Working with the MDR requires knowing how to work with clinical evidence. Medical doctors are perfectly positioned to meet this requirement.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  37. Software as a Medical Device

    Software as a Medical Device

    Unless you have spent time working with medical device legislation in the past, the idea that software could be a medical device may be rather unexpected.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  38. clinical investigator for pmcf eu mdr compliance

    Ensuring that clinical investigations work in practice

    How can medical device manufacturers ensure valid clinical investigations when access to medical expertise remains limited?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  39. Coronavirus and medical device regulations

    Relaxing medical device regulatory requirements during a healthcare crisis

    During the coronavirus pandemic, how far should we go when relaxing medical device regulatory requirements?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  40. The new MDR compliance challenge

    The new MDR compliance challenge

    Across the industry, medical device companies are facing challenges in meeting the demands of the new Medical Device Regulations (MDR) 2017/745 framework.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  41. Sources of Real World Evidence for MDR compliance

    Sources of Real World Evidence for MDR compliance

    At Mantra Systems our objective is to make sure that our clients choose the method of real world data harvesting that is right for them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer

More articles

Do you need support with your medical device approval strategy?

Contact us today